What's new

Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised

Mar 14, 2025 - 15:07
 0
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID...

Next Article

Spontaneous Passivation of Selective Zn (101) Plating via Dangling Bond Saturati...

Related Posts

Orphan designation: autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 Treatment of myasthenia gravis, 20/02/2025 Positive

Orphan designation: autologous T cells transduced with ...

Mar 12, 2025  0

Budesonide, prolonged release tablets, 9 mg product- specific bioequivalence guidance

Budesonide, prolonged release tablets, 9 mg product- sp...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Aerius, desloratadine, Date of authorisation: 15/01/2001, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0